To enhance the standardization of gynecologic oncology in western China and promote multidisciplinary diagnosis and treatment as well as precision medicine, the "Gynecologic Oncology Immunotherapy Forum," organized by the Chengdu High-Tech Medical Association, was successfully held in Chengdu on March 15, 2025. Upholding the principles of "standardization, precision, and focus" in gynecologic oncology diagnosis and treatment, the forum invited renowned domestic experts to deliver academic lectures on the latest advancements in the field.

       The successful hosting of this conference not only provided a platform for in-depth exchanges on cutting-edge research and technologies among experts and scholars but also served as a pivotal opportunity to drive innovation in gynecologic oncology treatment. It fostered multidisciplinary collaboration by integrating insights from basic research, clinical translation, and practical applications, thereby accelerating the implementation and optimization of immunotherapy in gynecologic oncology. Additionally, by sharing successful cases and addressing therapeutic challenges, the forum helped clinicians improve their diagnostic and treatment capabilities, enabling them to develop more precise and personalized treatment plans for patients. Furthermore, this collaborative platform contributed to building industry consensus, refining relevant policies, and optimizing the allocation of medical resources. Ultimately, it facilitated a virtuous cycle from research to clinical practice, advancing global women's health initiatives.